CELLEUROPE

Improving HSCT By Validation Of Biomarkers & Development Of Novel Cellular Therapies

 Coordinatore UNIVERSITY OF NEWCASTLE UPON TYNE 

 Organization address address: Kensington Terrace 6
city: NEWCASTLE UPON TYNE
postcode: NE1 7RU

contact info
Titolo: Mrs.
Nome: Helen
Cognome: Gallon
Email: send email
Telefono: +44 0 1912824513
Fax: +44 0 1912824524

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 3˙226˙319 €
 EC contributo 3˙226˙319 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2012-ITN
 Funding Scheme MC-ITN
 Anno di inizio 2012
 Periodo (anno-mese-giorno) 2012-10-01   -   2016-09-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    UNIVERSITY OF NEWCASTLE UPON TYNE

 Organization address address: Kensington Terrace 6
city: NEWCASTLE UPON TYNE
postcode: NE1 7RU

contact info
Titolo: Mrs.
Nome: Helen
Cognome: Gallon
Email: send email
Telefono: +44 0 1912824513
Fax: +44 0 1912824524

UK (NEWCASTLE UPON TYNE) coordinator 920˙805.70
2    UNIVERSITETET I OSLO

 Organization address address: Problemveien 5-7
city: OSLO
postcode: 313

contact info
Titolo: Ms.
Nome: Eva Helene
Cognome: Mjelde
Email: send email
Telefono: +47 22851180
Fax: +47 22851278

NO (OSLO) participant 561˙642.80
3    ALCYOMICS LTD

 Organization address address: BULMAN HOUSE REGENT CENTRE
city: NEWCASTLE UPON TYNE
postcode: NE3 3 LS

contact info
Titolo: Prof.
Nome: Anne
Cognome: Dickinson
Email: send email
Telefono: 441912000000
Fax: 441912000000

UK (NEWCASTLE UPON TYNE) participant 250˙652.16
4    MEDIZINISCHE UNIVERSITAET WIEN

 Organization address address: SPITALGASSE 23
city: WIEN
postcode: 1090

contact info
Titolo: Prof.
Nome: Christoph
Cognome: Zielinski
Email: send email
Telefono: 431404000000
Fax: +43140 400 4451

AT (WIEN) participant 240˙201.72
5    KLINIKUM DER UNIVERSITAET REGENSBURG

 Organization address address: FRANZ JOSEF STRAUSS ALLEE 11
city: REGENSBURG
postcode: 93053

contact info
Titolo: Ms.
Nome: Elisabeth
Cognome: Geiger
Email: send email
Telefono: 499419000000
Fax: 499419000000

DE (REGENSBURG) participant 222˙068.88
6    MEDIZINISCHE HOCHSCHULE HANNOVER

 Organization address address: Carl-Neuberg-Strasse 1
city: HANNOVER
postcode: 30625

contact info
Titolo: Mr.
Nome: Frank
Cognome: Dittrich
Email: send email
Telefono: 495115000000
Fax: 495115000000

DE (HANNOVER) participant 222˙068.88
7    UNIVERSITAETSMEDIZIN GOETTINGEN - GEORG-AUGUST-UNIVERSITAET GOETTINGEN - STIFTUNG OEFFENTLICHEN RECHTS

 Organization address address: Robert-Koch-Strasse 40
city: GOETTINGEN
postcode: 37075

contact info
Titolo: Ms.
Nome: Christiane
Cognome: Hennecke
Email: send email
Telefono: +49 551 39 8770
Fax: +49 551 3922593

DE (GOETTINGEN) participant 222˙068.88
8    UNIVERZITA KARLOVA V PRAZE

 Organization address address: Ovocny trh 5
city: PRAHA 1
postcode: 11636

contact info
Titolo: Mr.
Nome: Chlapec
Cognome: Jaromir
Email: send email
Telefono: 420267000000
Fax: 420267000000

CZ (PRAHA 1) participant 205˙208.52
9    KLINIKUM RECHTS DER ISAR DER TECHNISCHEN UNIVERSITAT MUNCHEN

 Organization address address: ISMANINGER STRASSE 22
city: MUENCHEN
postcode: 81675

contact info
Titolo: Ms.
Nome: Beate
Cognome: Schaulin
Email: send email
Telefono: +49 89 4140 2856
Fax: +49 89 4140 4926

DE (MUENCHEN) participant 190˙800.72
10    MILTENYI BIOTEC GMBH

 Organization address address: FRIEDRICH EBERT STRASSE 68
city: BERGISCH GLADBACH
postcode: 51429

contact info
Titolo: Dr.
Nome: Miriam
Cognome: Rode
Email: send email
Telefono: +49 2204 8306 4507
Fax: +49 2204 85197

DE (BERGISCH GLADBACH) participant 190˙800.72
11 MULTIMMUNE GMBH DE participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

clinical    gvhd    cellular    gvl    medicine    cgmp    therapies    lack   

 Obiettivo del progetto (Objective)

'Novel transplant regimens are currently being developed to improve beneficial GvL effects and reduce GvHD and infections via several new forms of cellular therapies. This newly emerging supra-disciplinary field of cellular therapy and regenerative medicine is also being used to improve outcomes in autoimmune disease (such as Rheumatoid Arthritis) and cancers. The goal of this research programme is to gain insight into the mechanisms of action of GvL and GvHD in order to improve current therapies and develop and test novel ones via clinical trials and/or animal model experiments. The research is therefore necessarily multidisciplinary including clinical medicine, immunology, genomics, proteomics, molecular biology and pathology. In order to implement cellular therapies across Europe the current EU Directive 2001/83/EC applies. These regulations stipulate that the cellular therapies which are advanced therapeutic medical products (ATMP) must be produced under current Good Manufacturing Practice (cGMP). Not only is there a lack of understanding of GvL vs. GvHD effects but there is also a lack of training in cGMP for both clinical and non-clinical scientists. We aim to re-address these basic current needs, as well as those of industry, which include lack of access to clinical tissue for validation of bio-markers prior to commercialisation.'

Altri progetti dello stesso programma (FP7-PEOPLE)

SIMPCCGAS (0)

Simulating and Simplifying the Physicochemical Complexity of Gas-Aerosol Systems to Promote Development of the Next Generation of Atmospheric 3-D Models

Read More  

SASDAPPIA (2013)

"Settlement and spatial dynamics along the Appian way, between the Suburbium and the city of Rome"

Read More  

STIFFMATRIXVASC (2013)

From extracellular matrix rigidity to vascular aging

Read More